MRH AMS Audit

Tigo, Merasol .

HRN: 13-38-73  Sex: Female

Patient Encounter

Audit Details

 Indication:  Prophylaxis    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

 Initial appropriateness: Yes     

 Final appropriateness: Yes     

 Overall appropriateness: Yes   

Intervention

 Type of Intervention done:

Discontinue antibiotic   IV to PO switch   Dosing/administration   Further investigations   Broaden empirical coverage   Narrow empirical coverage   Escalation based on culture results  

De-escalation based on culture results   Refer to Infectious Diseases Specialist   Implement infection/source control   Optimization of other concurrent antimicrobials   Other intervention

 Acceptance:

Yes No  

 If NO: